Literature DB >> 32669530

Prevalence of the Academic Research Consortium for High Bleeding Risk Criteria and Prognostic Value of a Simplified Definition.

Katsuya Miura1, Takenobu Shimada1, Masanobu Ohya1, Ryosuke Murai1, Hidewo Amano1, Shunsuke Kubo1, Takeshi Tada1, Hiroyuki Tanaka1, Yasushi Fuku1, Tsuyoshi Goto1, Kazushige Kadota1.   

Abstract

BACKGROUND: The Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria have been suggested as the standard definition of HBR. However, the prevalence of individual criteria and their prognostic value for long-term bleeding events after percutaneous coronary intervention are scarcely studied.Methods and 
Results: The study population comprised 1,193 patients treated with everolimus-eluting stents between 2010 and 2011. Data on all 17 major and minor criteria of the ARC-HBR definition were retrospectively collected, and applied to this study population. Major bleeding was defined as the occurrence of a BARC type 3 or 5 bleeding event. A simplified definition was developed by excluding the low-frequency criterion, and the prognostic value was assessed by a receiver-operating characteristic curve. Mean follow-up was 2,996±433 days and there were 656 HBR patients (55.0%). The cumulative incidence of major bleeding was significantly higher in the HBR group than in the non-HBR group (16.2% vs. 5.7% at 8 years, P<0.001). The frequencies of 6 of the 17 criteria were less than 1%. The prognostic value of the simplified definition made by excluding these 6 criteria for major bleeding was comparable to that of the original (c-statistic=0.598 and 0.600, P=0.08).
CONCLUSIONS: Some risk criteria of the ARC-HBR definition are observed infrequently. Our simplified definition identified patients with long-term bleeding risk as successfully as the original definition.

Entities:  

Keywords:  Bleeding; Coronary artery disease; Percutaneous coronary intervention

Year:  2020        PMID: 32669530     DOI: 10.1253/circj.CJ-20-0395

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  3 in total

1.  Ischemic and Bleeding Outcomes According to the Academic Research Consortium High Bleeding Risk Criteria in All Comers Treated by Percutaneous Coronary Interventions.

Authors:  Daphné Doomun; Ianis Doomun; Sara Schukraft; Diego Arroyo; Selma Cook; Tibor Huwyler; Peter Wenaweser; Jean-Christophe Stauffer; Jean-Jacques Goy; Mario Togni; Serban Puricel; Stéphane Cook
Journal:  Front Cardiovasc Med       Date:  2021-12-02

2.  Correlation Between the Japanese Version of the High Bleeding Risk (J-HBR) Criteria and the PRECISE-DAPT Score, and Optimal J-HBR Cut-Off Score to Predict Major Bleeding.

Authors:  Naoki Kubota; Kazuyuki Ozaki; Takumi Akiyama; Yuzo Washiyama; Shintaro Yoneyama; Takeshi Okubo; Ryutaro Ikegami; Makoto Hoyano; Takao Yanagawa; Naohito Tanabe; Takayuki Inomata
Journal:  Circ Rep       Date:  2022-06-30

3.  Clinical Outcomes of Ticagrelor in Korean Patients with Acute Myocardial Infarction without High Bleeding Risk.

Authors:  Keun-Ho Park; Myung Ho Jeong; Hyun Kuk Kim; Young-Jae Ki; Sung Soo Kim; Dong-Hyun Choi; Young-Youp Koh; Youngkeun Ahn; Hyo-Soo Kim; Hyeon-Cheol Gwon; Seung-Woon Rha; Jin-Yong Hwang
Journal:  J Korean Med Sci       Date:  2021-11-01       Impact factor: 2.153

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.